6 April 2020
Are you an Australian manufacturer with the capability to produce inputs for COVID-19 RNA extraction? Do you have support to scale up your production?
We want to hear from you. Securing Australia’s COVID-19 testing capacity is one of the Australian Government’s highest priorities.
We are seeking responses via AusTender by 17 April 2020.
We’re already working with Australian companies who produce inputs for RNA extraction and PCR testing by ensuring their supply chains can continue to support production.
While the global market is adjusting and scaling up to meet heightened demand, Australia’s ability to manufacture testing kits locally will reduce our vulnerability to global supply chain disruption.
Manufacturing domestically may also contribute to global testing capacity.
Find out more and submit your capability to assist here.
Read the media release here.
From AusTender
: 17-Apr-2020 5:00 pm (ACT Local Time)
: The Department of Industry, Science, Energy and Resources (the Department) is mapping domestic production capability of specific components needed for the SARS-COV2 RT-PCR based early detection test kit. The Department is seeking information on domestic capabilities to manufacture and potential to increase capacity to manufacture a range of components of the test including viral transport medium, nucleic acid extraction kits, essential chemical inputs, and automated nucleic acid extraction platforms.
: ACT, NSW, VIC, SA, WA, QLD, NT, TAS
Canberra, Sydney, Melbourne, Adelaide, Perth, Brisbane, Darwin, Hobart
: Request for Information
Find out more and submit your capability to assist here.
Read the media release here.
